Antibiotics for Pseudomonas Folliculitis
For Pseudomonas folliculitis, ciprofloxacin 750 mg orally twice daily for 14 days is the recommended first-line treatment, as it is the only reliable oral antibiotic with consistent antipseudomonal activity. 1, 2
First-Line Oral Treatment
- Ciprofloxacin 750 mg PO twice daily for 14 days is the definitive oral choice for Pseudomonas folliculitis 1, 2, 3
- This high-dose regimen is essential because standard doses (500 mg twice daily) are insufficient for Pseudomonas infections 1
- Ciprofloxacin achieves excellent oral bioavailability matching IV levels, with sputum concentrations reaching 46-90% of serum levels 1
- The 14-day duration is standard for Pseudomonas infections, not the 7-10 days used for other pathogens 2
When to Use Intravenous or Combination Therapy
Escalate to IV therapy or combination treatment if:
- The patient is severely ill, immunocompromised, or has failed oral therapy 1, 2
- There is documented resistance or high local prevalence of multidrug-resistant Pseudomonas 1
- The patient has structural skin disease or recurrent folliculitis 1
For severe cases requiring IV therapy, use an antipseudomonal β-lactam PLUS a second agent: 1, 2
IV β-Lactam Options (choose one):
- Piperacillin-tazobactam 4.5g IV every 6 hours 1
- Ceftazidime 2g IV every 8 hours 1, 2
- Cefepime 2g IV every 8 hours 1, 2
- Meropenem 1g IV every 8 hours 1, 2
PLUS Second Agent (choose one):
- Tobramycin 5-7 mg/kg IV once daily (preferred over gentamicin due to lower nephrotoxicity) 1, 2
- Ciprofloxacin 400 mg IV every 8 hours 1
Critical Pitfalls to Avoid
- Never use ceftriaxone, cefazolin, ampicillin-sulbactam, or ertapenem - these lack antipseudomonal activity despite being broad-spectrum agents 1
- Never underdose ciprofloxacin - 500 mg twice daily is inadequate; always use 750 mg twice daily for Pseudomonas 1
- Never stop treatment at 7-10 days - this increases relapse and resistance risk; complete the full 14-day course 2
- Never extend oral ciprofloxacin monotherapy beyond 14 days - this promotes resistance without proven benefit 1
- Never assume monotherapy is adequate for severe infections - combination therapy delays resistance development 4, 1
Monitoring and Follow-Up
- Obtain culture and sensitivity testing before starting antibiotics to confirm Pseudomonas and guide therapy 1, 2
- If no clinical improvement by day 3-5, switch to IV combination therapy 1
- Monitor for resistance development, particularly when initial MIC >0.5 mg/L 5
- Obtain follow-up cultures to document eradication 2
Special Considerations
- Levofloxacin 750 mg daily is a less potent alternative to ciprofloxacin and should only be used as second-line 1, 6
- For hot tub folliculitis (Pseudomonas aeruginosa), the same treatment principles apply with prompt recognition to prevent further cases 7
- Resistance can develop during treatment in 9-30% of cases, especially with inadequate dosing or when MIC is initially elevated 8, 5
- Once susceptibility results are available and the patient is improving, de-escalation to monotherapy is appropriate if the organism is susceptible 1